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Neutrophil extravasation is a central process of 
the immune system that enables neutrophils to 
survey the body and to reach sites of infection. 
Inflammatory signals lead to the expression of 
endothelial  surface  receptors  such  as  E-  and   
P-selectin that mediate capturing and rolling of 
neutrophils on the vessel wall. 2-Integrins on 
neutrophils  further  slow  down  rolling  and, 
triggered by chemokines, mediate neutrophil 
arrest followed by crawling and eventually dia-
pedesis  through  the  blood  vessel  wall  (Ley   
et al., 2007; Schnoor and Parkos, 2008). These 
processes require the coordinated function of 
adhesion receptors, the cytoskeleton, and signal-
ing molecules (Vestweber, 2007). During these 
processes, vascular permeability is usually in-
creased, which may cause complications such 
as edema formation or sepsis if not properly 
controlled (Kumar et al., 2009).
Inflammatory stimuli that trigger leukocyte 
adhesion and transmigration also cause cyto-
skeletal rearrangements allowing for the mor-
phological changes required for the opening of 
endothelial cell contacts and for the accom-
modation of leukocytes moving through these 
openings (Alcaide et al., 2009; van Buul and 
Hordijk, 2009). Especially in the cellular cortical 
regions, actin filaments are in a highly dynamic 
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Neutrophil extravasation and the regulation of vascular permeability require dynamic actin 
rearrangements in the endothelium. In this study, we analyzed in vivo whether these pro-
cesses require the function of the actin nucleation–promoting factor cortactin. Basal 
vascular permeability for high molecular weight substances was enhanced in cortactin-
deficient mice. Despite this leakiness, neutrophil extravasation in the tumor necrosis  
factor–stimulated cremaster was inhibited by the loss of cortactin. The permeability defect 
was caused by reduced levels of activated Rap1 (Ras-related protein 1) in endothelial cells 
and could be rescued by activating Rap1 via the guanosine triphosphatase (GTPase) ex-
change factor EPAC (exchange protein directly activated by cAMP). The defect in neutro-
phil extravasation was caused by enhanced rolling velocity and reduced adhesion in 
postcapillary venules. Impaired rolling interactions were linked to contributions of  
2-integrin ligands, and firm adhesion was compromised by reduced ICAM-1 (intercellular 
adhesion molecule 1) clustering around neutrophils. A signaling process known to be  
critical for the formation of ICAM-1–enriched contact areas and for transendothelial 
migration, the ICAM-1–mediated activation of the GTPase RhoG was blocked in cortactin-
deficient endothelial cells. Our results represent the first physiological evidence that cor-
tactin is crucial for orchestrating the molecular events leading to proper endothelial barrier 
function and leukocyte recruitment in vivo.
© 2011 Schnoor et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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neutrophils to move through the endothelial barrier, other 
studies reported that cortactin seems to support the stabiliza-
tion and closing of the endothelial barrier, as found for the 
barrier-enhancing effects of sphingosine-1-phosphate (S1P) 
and ATP  on  endothelial  monolayers  (Dudek  et  al.,  2004;   
Jacobson et al., 2006). A role of cortactin for the mainte-
nance of endothelial barrier integrity was not detected in   
these studies.
In this study, we have analyzed in vivo whether cortactin is 
relevant for the barrier function of endothelial cells. For this 
purpose, we generated and analyzed cortactin-deficient mice. 
state that is nevertheless tightly regulated to facilitate sophis-
ticated processes such as leukocyte adhesion and transmigra-
tion (Revenu et al., 2004). Adhesion of leukocytes to the 
endothelium is accompanied by the formation of endothelial 
adhesive structures that support firm adhesion and arrest of 
leukocytes and are enriched in the integrin ligand ICAM-1 
(intercellular adhesion molecule-1) and filamentous actin   
(F-actin; Barreiro et al., 2002; Carman et al., 2003).
Cortactin is an actin-binding protein that promotes actin 
assembly (Ammer and Weed, 2008). Cortactin is ubiquitously 
expressed except for leukocytes that instead express the   
cortactin-related protein HS1 (hematopoietic cell–specific Lyn 
substrate 1; Kitamura et al., 1989; Burkhardt et al., 2008). 
Cortactin has a multidomain structure consisting of binding 
regions for the Arp2/3 (actin-related protein 2/3) complex 
and F-actin. These domains are followed by a proline-rich   
region containing several serine/threonine/tyrosine residues 
that are targets for different kinases and an SH3 (Src homol-
ogy 3) domain at the C terminus through which cortactin 
can bind to a plethora of different proteins (Cosen-Binker 
and  Kapus,  2006).  Cortactin  and  HS1  were  previously   
observed to increase Arp2/3 complex–dependent actin as-
sembly in vitro, although the potency of Arp2/3 complex ac-
tivation is below that of canonical, so-called type I Arp2/3 
complex activators such as Wiskott-Aldrich syndrome protein 
(WASP) or WAVE (Uruno et al., 2003; Goley and Welch, 
2006). Cortactin can also collaborate with the type I Arp2/3 
complex  activator  N-WASP  (neural WASP; Weaver  et  al., 
2002),  both  of  which  were  concluded  to  promote Arp2/ 
3-dependent actin remodeling events such as cell migration 
(Kowalski  et  al.,  2005).  However,  interpretation  of  these   
results is complicated by an increase rather than decrease in 
cell  migration  rates  observed  in  N-WASP–defective  cells 
(Misra et al., 2007) and by the recently determined less direct 
role that cortactin plays in this process. More specifically, cor-
tactin is not required for the activation of Arp2/3 complex in 
lamellipodia or at sites of endocytosis, but instead appears to 
modulate the signaling pathways driving their formation (Lai 
et al., 2009). Consistent with this, HS1 is also dispensable for 
spreading and lamellipodia formation in platelets (Thomas   
et al., 2007). Clearly, the precise function of cortactin and 
HS1 in Arp2/3-dependent actin remodeling in vivo appears 
elusive to date.
In vitro studies of endothelial cells have provided some 
evidence for possible functions of cortactin in endothelial 
cells. Cross-linking of ICAM-1 was reported to stimulate tyro-
sine phosphorylation of cortactin (Durieu-Trautmann et al., 
1994; Adamson et al., 1999) and enabled coprecipitation of 
cortactin  with  ICAM-1  (Tilghman  and  Hoover,  2002).   
Silencing of cortactin by small interfering RNA (siRNA) was 
found to inhibit transmigration of neutrophils through endo-
thelial cell monolayers, but although this was accompanied   
by reduced accumulation of ICAM-1 at sites of neutrophil 
attachment, it did not affect adhesion of neutrophils to the 
endothelial cell surface (Yang et al., 2006a,b). In contrast to 
these results that suggest that endothelial cortactin may help 
Figure 1.  Generation of cortactin-deficient mice. (A) Domain orga-
nization of the cortactin protein and gene targeting strategy showing the 
partial genomic organization of the Cttn locus in WT, targeted, loxP-
flanked (floxed), and deleted alleles. The vector carrying a neomycin resis-
tance cassette (described previously in Lai et al. [2009]) to target the WT 
cortactin allele by homologous recombination in murine ES cells is depicted. 
Targeted ES cells were injected into blastocysts as described in Materials 
and methods. (B) PCR genotyping of mice carrying the WT and deleted 
(KO) alleles after consecutive crosses with mice expressing Flp and Cre 
recombinase. The top and bottom bands indicate the presence of WT Cttn 
allele (WT) and the deleted allele (KO), respectively. (C) Western blot analysis of 
different organ lysates derived from WT or cortactin-deficient mice (KO).JEM Vol. 208, No. 8 
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In a specific pathogen-free environment, adult CttnWT/del 
mice in a mixed genetic background were backcrossed with 
C57BL/6 mice. Cttndel/del mice of the sixth backcross were 
used in our experiments. Cttndel/del mice of mixed genetic 
background and of the sixth backcross showed no obvious 
phenotype, were healthy by visual inspection, and had a normal 
life span. Thus, cortactin is not essential for normal develop-
ment, and its absence does not cause any obvious defects   
under specific, pathogen-free conditions.
Breeding CttnWT/del mice on a mixed 129Sv/C57BL/6 
background generated homozygous Cttndel/del mice with nor-
mal Mendelian frequency (Table S1), although we found a 
significant preference toward female offspring. When hetero-
zygous mice of the sixth backcross (C57BL/6) were mated, 
Cttndel/del mice were clearly underrepresented among the off-
spring (Table S2). The reason for this is currently unknown.
Loss of cortactin leads to increased vascular  
permeability in vivo
Based on RNA silencing in cultured endothelial cells, it has 
been suggested that cortactin is required for the enhancement 
of endothelial cell contact integrity by S1P or ATP; however, 
basal barrier integrity was unaffected (Dudek et al., 2004;   
Jacobson et al., 2006). This prompted us to use the Miles   
assay to test whether cortactin gene deficiency would affect 
vascular permeability in the skin. To this end, we injected 
WT and Cttndel/del mice i.v. with Evans blue followed by   
intradermal injection of either histamine or PBS 15 min later. 
Remarkably, in the absence of any permeability-stimulating 
factor, the permeability in Cttndel/del mice was more than two-
fold higher than in WT mice (Fig. 2 A), clearly demonstrat-
ing that cortactin controls basal permeability. Stimulation 
with histamine resulted in an additional increase of permea-
bility in Cttndel/del mice as compared with WT mice (Fig. 2 A). 
We conclude that cortactin is required in vivo to maintain 
basal barrier integrity within blood vessels.
To  test  whether  the  composition  of  membrane 
proteins at endothelial cell contacts would be disturbed 
in cortactin-deficient mice, we first analyzed the over-
all expression levels of vascular endothelial cadherin 
(VE-cadherin), endothelial cell–selective adhesion mol-
ecule (ESAM), JAM-A (junctional adhesion molecule A), 
We analyzed the blood vessel barrier function with respect to 
neutrophil extravasation and vascular permeability for large 
molecular weight substances. We found that neutrophil extrava-
sation into the TNF-stimulated cremaster was strongly reduced. 
Unexpectedly, this was caused by impaired neutrophil endothe-
lial interactions as documented by increased rolling velocity and   
reduced leukocyte adhesion. Neutrophil rolling and firm adhe-
sion were both supported by cortactin via 2-integrin ligands. In 
contrast to the reduction of leukocyte extravasation, cortactin 
deficiency enhanced basal vascular permeability.
RESULTS
Generation and characterization of cortactin-deficient mice
To investigate the physiological role of cortactin, we used a 
conditional gene ablation approach by flanking exon 7 with 
loxP sites. The targeting vector was described previously (Lai 
et al., 2009), and the gene targeting strategy is outlined in 
Fig. 1 A. Consecutive crosses with mice systemically ex-
pressing Flp (to remove the neo-cassette) and Cre recombi-
nase were performed to produce the null mutation on a 
mixed genetic background. Mice homozygous for the null 
mutation were successfully obtained by crossing mice with 
genotype del/WT. Deletion of exon 7 in the cortactin gene 
by Cre recombinase expressed in oocytes was expected to 
stop the reading frame generating a null allele in all cells of 
the organism. PCR genotyping of tail DNA samples revealed 
successful deletion of exon 7 (Fig. 1 B), and immunoblotting 
confirmed the absence of cortactin protein in homozygous 
del/del animals (KO) in any organ analyzed, as expected   
(Fig. 1 C). Using fibroblasts derived from double-targeted 
embryonic stem (ES) cells, in which deletion of exon 7 was 
induced in a comparable fashion in vitro, RT-PCR with 
primer pairs corresponding to regions of the 5 end and the 
3 end of the cortactin message did not reveal any detectable 
cortactin transcript, as shown by Lai et al. (2009).
Figure 2.  Cortactin deficiency leads to increased vascular 
permeability in vivo. (A) Cttndel/del and CttnWT/WT mice were  
injected i.v. with Evans blue and 10 min later intradermally with 
histamine or PBS alone. Animals were sacrificed after an addi-
tional 30 min, and the dye was extracted from skin samples and 
quantified. Data are presented as means ± SD. n = 12 (WT); n = 11 
(KO). ***, P < 0.001. Four independent assays with three to four 
mice per group were performed. (B) Lung lysates from Cttndel/del 
(KO) and CttnWT/WT (WT) mice were analyzed by Western blot and 
probed for the indicated proteins. A representative blot from three 
independent experiments is shown. (C) Whole mount stainings of 
cremaster muscles from Cttndel/del (KO) and CttnWT/WT (WT) mice for 
VE-cadherin and ESAM. Images are representative for three inde-
pendent preparations each. Bars, 50 µm.1724 Cortactin regulates endothelial barrier functions | Schnoor et al.
contacts, we investigated whether activation of Rap1 reverses 
the cortactin knockdown effect on endothelial permeability. 
To this end, we stimulated HUVECs with the cAMP analogue 
claudin-5, and also ICAM-1 in Western blots of the lung. As 
shown in Fig. 2 B, no difference was found in comparison 
with WT mice. Likewise, junctional localization of VE-
  cadherin and ESAM was unaffected by cortactin gene disrup-
tion, as shown by whole mount stainings of venules in the 
cremaster (Fig. 2 C). Relative pixel intensity in venules of the 
KO tissue was 107.9 ± 12.7% for ESAM and 102.9 ± 8.7% 
for VE-cadherin with pixel intensity for the WT values set to 
100%. Isolation of primary endothelial cells from lungs of 
Cttndel/del mice and CttnWT/WT mice (murine lung endothelial 
cells [MLECs]) allowed us to compare constitutive cell sur-
face  expression  levels  of  VE-cadherin,  ESAM,  JAM-A,   
and PECAM-1 and expression of TNF-induced ICAM-1, 
VCAM-1 (vascular cell adhesion molecule 1), E-selectin, and 
P-selectin by flow cytometry. Each of these adhesion mole-
cules was expressed at similar levels on both cell types (Fig. S1).
Inhibiting the expression of cortactin affects Rap-1  
(Ras-related protein 1) activation and endothelial cell 
contact integrity
To elucidate the mechanism whereby cortactin supports cell 
contact integrity, we established siRNA-mediated down-
regulation of the expression of cortactin in cultured human 
and mouse endothelial cells. Cortactin expression could be 
inhibited by 89% in human umbilical vein endothelial cells 
(HUVECs; Fig. 3 A) and by 81% in bend.3 mouse endothe-
lioma cells (Fig. S4). Suppression of cortactin expression was 
accompanied by a 29.8% (±8.6%) increase of paracellular flux 
of 250-kD FITC-dextran across the monolayer of HUVECs 
grown on transwell filters (Fig. 3 C). Similar results were   
obtained for bend.3 mouse endothelioma cells (Fig. S4). 
Confluent monolayers of Cttndel/del MLECs had 68% (±23%) 
higher  permeability  than  CttnWT/WT  MLECs  for  250  kD 
FITC-dextran  and  19%  (±4%)  enhanced  permeability  for 
150-kD FITC-dextran (Fig. 3 E). In line with this, we found 
a  53%  (±6.3%)  reduction  of  transendothelial  resistance  of 
HUVEC monolayers (Fig. 3 D), confirming our in vivo 
finding that cortactin is indeed required for maintaining endo-
thelial cell contact integrity.
Because it was shown before that activation of the Epac 
(exchange protein directly activated by cAMP)/Rap-1 path-
way leads to stabilization of endothelial cell contacts (Cullere 
et al., 2005; Kooistra et al., 2005), we tested whether down-
regulation of the expression of cortactin affects the levels of 
GTP-loaded Rap-1. Indeed, siRNA-mediated silencing of 
cortactin reduced the levels of activated Rap-1 by 41.7% 
(±9.4%) in HUVECs (Fig. 4 A) and by 74% (±17%) in bend.3 
cells (Fig. S4). Likewise, levels of activated Rap1 were re-
duced by 51% (±6.7%)% in Cttndel/del MLECs compared with 
CttnWT/WT MLECs (Fig. 4 A). Thus, cortactin is required to 
maintain the steady-state levels of GTP loading of Rap1.
Stimulating Epac/Rap-1 compensates the loss of cell 
contact integrity caused by down-regulation of cortactin
To test whether the reduction of Rap1 activation levels could 
explain why the loss of cortactin destabilizes endothelial cell 
Figure 3.  Silencing or deficiency of cortactin enhances permeabil-
ity of cultured endothelial cell layers. (A) HUVECs were transfected 
with either control (ctrl) or cortactin-specific siRNAs. 48 h later, cell  
lysates were immunoblotted for cortactin expression (top). Cortactin immuno-
blots of primary MLECs isolated from CttnWT/WT (WT) and Cttndel/del (KO) 
mice are shown. Equal loading was controlled by blotting for tubulin  
(bottom). Blots are representative of four independent experiments.  
(B) Micrographs of HUVEC monolayers transfected with control and cortactin 
siRNA and MLEC monolayers of CttnWT/WT (WT) and Cttndel/del (KO) mice 
grown on transwell filters parallel to the experiment shown in C–E stained 
for VE-cadherin. Images are representative of four independent experi-
ments. Bar, 20 µm. (C) Paracellular permeability for 250-kD FITC-dextran 
was determined for HUVECs transfected without oligonucleotides (set to 
100%) or with either control or cortactin-specific siRNAs cultured on 
transwell filters (0.4-µm pore size). (D) Measurement of transendothelial 
electrical resistance (TER) of HUVECs treated as described in C. (E) Para-
cellular permeability of MLECs from CttnWT/WT (WT) and Cttndel/del (KO) mice 
for 250 kD (left) and 150 kD FITC-dextran (right). (C–E) All data are  
means ± SD. n = 6 for each group in three independent experiments.  
*, P < 0.05; **, P < 0.005.JEM Vol. 208, No. 8 
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(Videos 1 and 2). We conclude that the slowing down of rolling 
neutrophils was less efficient in Cttndel/del mice leading to faster 
rolling cells and a defect in neutrophil arrest. Because of this 
defect, cells continued to roll instead of stopping as firmly ad-
hering cells, leading to increased numbers of rolling cells at the 
expense of firmly adhering cells. Thus, cortactin is required for 
optimal neutrophil extravasation efficiency at a step upstream 
of the actual transmigration process.
To determine whether cortactin acts in endothelial cells 
or in neutrophils during the extravasation process, we first 
analyzed whether it is expressed in neutrophils. In agreement 
with a previous study that reported the absence of cortactin 
in all bone marrow–derived cells except megakaryocytes 
(Zhan et al., 1997), we could not detect cortactin in immuno-
blots of mouse leukocyte lysates (Fig. S2). However, this   
did not rule out the possibility that low expression levels of 
cortactin below detection levels might be sufficient to sup-
port functions relevant for leukocyte extravasation. To test 
this, we generated chimeric mice by irradiating WT mice 
and transplanting them with bone marrow cells from either 
Cttndel/del mice or (as controls) from CttnWT/WT littermates. 
Intravital microscopy of the TNF-inflamed cremaster of these 
mice revealed no differences in rolling velocity, rolling flux 
fraction, or in the number of adherent or extravasated neu-
trophils when compared with WT mice transplanted with 
WT bone marrow (Fig. 5, E–H). These results formally rule 
out the possibility that cortactin potentially expressed below 
detection limit in neutrophils participates in their extravasa-
tion. In addition, these experiments exclude the possibility 
that platelets, which do express cortactin (Vidal et al., 2002) 
and are known to be important for neutrophil recruitment 
into inflamed tissue (Bixel et al., 2010), would require cor-
tactin for their participation in neutrophil extravasation.
Importantly, cortactin gene disruption did neither reduce 
peripheral leukocyte counts nor cause any changes in the rep-
ertoire of leukocyte surface molecules relevant for leukocyte 
8-pCPT-2Me-cAMP  (8-(4-Chlorophenylthio)-2’-O-methyl-
cAMP; or 007) known to specifically activate the GTPase 
exchange factor Epac and thereby Rap1. As shown in Fig. 4 C, 
8-pCPT-2Me-cAMP treatment of HUVECs transfected with 
cortactin-specific  siRNA  completely  compensated  the  in-
crease of FITC-dextran permeability caused by cortactin 
siRNA. In fact, the cAMP analogue reduced permeability   
to  the  same  level  in  cortactin  knockdown  and  control   
HUVECs. Similar results were obtained for bend.3 mouse 
endothelioma cells (Fig. S4) and for primary Cttndel/del MLECs 
(Fig. 4 D and Fig. S5). This reveals that direct stimulation of 
Epac/Rap1 can stabilize cell contacts, and this is independent 
of cortactin function. In agreement with this, direct stimula-
tion of Epac/Rap1 with 007 was not affected by the loss of 
cortactin in HUVECs or MLECs (Fig. 4 B). Because the loss 
of cortactin in turn leads to reduced activation levels of Rap1, 
our results position Epac/Rap1 downstream of cortactin.
Loss of cortactin inhibits neutrophil recruitment in vivo
The impairment of the vascular barrier function in cortactin-
deficient mice prompted us to test whether this would also   
affect the extravasation of leukocytes. Analyzing TNF-inflamed 
cremaster tissue by intravital microscopy, we found that despite 
the loss of barrier integrity, neutrophil extravasation was not 
enhanced. Instead, it was strongly reduced by 50.8% (±22.8%; 
Fig. 5 D). Analyzing neutrophil rolling and firm adhesion, we 
found that the defect in extravasation was caused by impaired 
interactions of neutrophils with the vessel wall. Neutrophil roll-
ing velocity was increased by 69.5% (±26.7%) in Cttndel/del mice 
when compared with WT mice (Fig. 5 A), and the rolling flux 
fraction was increased by 105% (±27.6%; Fig. 5 B). In line with 
these results, the number of neutrophils that firmly adhered to 
the endothelium was reduced by 40.6% (±23.4%) in Cttndel/del 
mice compared with littermate controls (Fig. 5 C). Hemo-
dynamic parameters of the analyzed vessels are given in Table I, 
and representative videos are shown in the supplemental material 
Figure 4.  Loss of cortactin leads to de-
creased levels of active Rap1, and Epac 
activation fully compensates the effect on 
permeability caused by down-regulation 
of cortactin. (A) Western blot analysis of 
pull-down assays for active Rap1 in HUVECs 
transfected with either control (ctrl) or  
cortactin-specific siRNA and for primary 
MLECs from CttnWT/WT (WT) and Cttndel/del (KO) 
mice. Total Rap1 levels were controlled by 
blotting aliquots of the whole cell lysates 
from which the pull-downs were performed. 
(B) Rap1 activation assays as in (A) performed 
with HUVECs transfected with either control 
or cortactin-specific siRNA or of MLECs from 
CttnWT/WT (WT) and Cttndel/del (KO) mice and additionally treated with 100 µM 8-pCPT-2Me-cAMP (+007) or vehicle (007). (A and B) The depicted immuno-
blots are representative of three similar experiments. (C) Permeability for 250-kD FITC-dextran was analyzed in HUVECs transfected with either control  
or cortactin-specific siRNA and treated with either 100 µM 8-pCPT-2Me-cAMP (007) or vehicle. (D) Permeability for 250-kD FITC-dextran was analyzed in 
MLECs from CttnWT/WT (WT) and Cttndel/del (KO) mice as described for HUVECs in C. (C and D) Graphs are representative of three independent experiments. 
All data are presented as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.1726 Cortactin regulates endothelial barrier functions | Schnoor et al.
cortactin that impairs leukocyte extravasation in cortactin-
deficient mice.
Cortactin deficiency impairs the ability of endothelial  
2-integrin ligands to slow down leukocyte rolling
Leukocyte rolling is initiated by the endothelial selectins and 
slowed down by the binding of the 2-integrins LFA-1 (lym-
phocyte function–associated antigen 1) and Mac-1 (macro-
phage 1 antigen) to their endothelial ligands (Kunkel et al., 
2000; Dunne et al., 2002). Thus, the enhanced leukocyte 
rolling velocity in cortactin-deficient mice could have either 
been caused by impaired selectin-mediated rolling or by the 
inability of endothelial 2-integrin ligands to slow down leuko-
cyte rolling. To test the second possibility, we determined 
whether cortactin deficiency would still affect the rolling ve-
locity when LFA-1 and Mac-1 are simultaneously blocked 
with antibodies. As shown in Fig. 5 I, we found that blocking 
LFA-1 and Mac-1 resulted in the expected strong increase in 
rolling velocity in CttnWT/WT mice. Importantly, these anti-
bodies had no further effect on the rolling velocity in Cttndel/del 
mice compared with CttnWT/WT mice (Fig. 5 I). This demon-
strates that the lack of cortactin did no longer enhance the 
rolling velocity if only the endothelial selectins but not the 
2-integrins were available to support rolling. This suggests in-
directly that cortactin supports neutrophil rolling via 2-integrin 
ligands and not via endothelial selectins.
Cortactin is required for proper functioning of ICAM-1  
in neutrophil extravasation
Our intravital microscopy results (Fig. 5) suggest that the   
defect in neutrophil extravasation in cortactin-deficient mice 
is caused by impaired neutrophil rolling and firm adhesion.   
To investigate how cortactin could affect transmigration, we 
decided to test whether we can recapitulate this effect in vitro. 
To exclude the rolling aspect, we performed static transmigra-
tion assays with endothelial cell monolayers grown on trans-
well filters. In agreement with the in vivo results, cortactin 
siRNA inhibited transmigration of human neutrophils through 
HUVEC monolayers by 36% (Fig. 6 A) and of mouse neutro-
phils through bend.5 cell layers by 40% (Fig. S4). Likewise, 
transmigration of mouse neutrophils through monolayers of 
primary MLECs isolated from Cttndel/del mice was reduced   
by 49% in comparison with MLECs from CttnWT/WT mice   
(Fig. 6 B). Neutrophils adhered to Cttndel/del MLECs with sim-
ilar efficiency (51.8 ± 4.1% of applied PMNs) as to CttnWT/WT 
MLECs (52.9 ± 6.8% of applied PMNs), possibly reflecting 
the fact that assays were performed under static conditions.
Because ICAM-1 is the major endothelial adhesion re-
ceptor relevant for firm neutrophil binding, we tested whether 
cortactin  would  influence  neutrophil  transmigration  via 
ICAM-1. If this was the case, knockdown of cortactin ex-
pression would have no inhibitory effect on neutrophil trans-
migration in endothelial cells lacking ICAM-1. To test this 
hypothesis, we used mouse endothelioma cells deficient for 
ICAM-1 and, as a control, the same cells retransfected for 
ICAM-1. Expression levels of cortactin in these endothelioma 
extravasation. Indeed, we did find a slight tendency toward 
higher numbers of neutrophils and lymphocytes in the blood 
of Cttndel/del animals compared with WT controls; however, 
the differences were not statistically significant (Fig. S2). Fur-
thermore, neither platelet nor erythrocyte counts were sig-
nificantly affected by cortactin gene disruption. In addition, 
surface expression of L-selectin, PSGL-1 (P-selectin glyco-
protein ligand 1), Gr-1, CD11a, CD11b, CD44, and CXCR2 
was not affected by the systemic loss of cortactin (Fig. S2). 
Collectively, our results suggest that it is the lack of endothelial 
Figure 5.  Cortactin is required for leukocyte rolling, adhesion, and 
transmigration in vivo. (A–D) The velocity of rolling cells (A), the rolling 
flux fraction (B), the number of firmly adherent cells (C), and the number 
of transmigrated cells (D) were investigated by intravital video microscopy 
and reflected light oblique transillumination microscopy of cremaster 
muscle venules of Cttndel/del (KO) and CttnWT/WT (WT) mice. Inflammation 
was induced by intrascrotal injection of 500 ng TNF 3 h before analysis. 
The results are displayed as mean ± SD of at least 20 vessels from four 
different animals in each group. ***, P < 0.0005. (E–H) Chimeric mice gen-
erated by transplanting bone marrow from WT animals or from cortactin-
deficient mice (KO) into lethally irradiated WT mice were analyzed by 
intravital microscopy of cremaster as for A–D. The velocity of rolling cells (E), 
the rolling flux fraction (F), the number of firmly adherent cells (G), and 
the number of transmigrated cells (H) were determined and showed no 
significant differences between the two types of chimeras. Results were 
obtained from three mice per group. (I) Leukocyte rolling velocity in venules 
of TNF-stimulated cremaster was determined as in A and E from Cttndel/del 
(KO) and CttnWT/WT (WT) mice that had been injected with a combination 
of anti–LFA-1 and anti–Mac-1 blocking antibodies (30 µg of each per 
mouse) just before cremaster muscle exteriorization. No-antibody con-
trols are shown in A. Results were determined from four mice per group.JEM Vol. 208, No. 8 
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facilitates the transmigration process (Barreiro et al., 2002; 
Carman et al., 2003). Therefore, we tested whether ICAM-1 
clustering would be dependent on the expression of cortactin.
We observed in control-transfected HUVECs ICAM-1–
  enriched ring-like structures surrounding adherent neutro-
phils. Cortactin was also enriched in these structures, partly 
colocalizing with ICAM-1 (Fig. 7 A). Importantly, after 
down-regulation of cortactin expression by siRNA, only very 
few of such structures were still observed, and the vast major-
ity of neutrophils were devoid of these rings (Fig. 7 A). We 
quantified the effect on the formation of ICAM-1–containing 
rings at sites of neutrophil contact (Fig. 7 B). More than 79% 
of PMNs on cortactin-positive cells showed closed ICAM-1–
positive ring structures, whereas 21% of adherent cells on 
cortactin-positive HUVECs were not surrounded by such 
structures. The situation was completely different for PMNs 
cells were similar to bend.3 or bend.5 cells (not depicted), and 
siRNA transfection reduced cortactin expression by 87% in 
ICAM-1–deficient cells and by 83% in ICAM-1–retransfected 
cells (Fig. 6 D).
As shown in Fig. 6 E, ICAM-1 deficiency reduced neu-
trophil transmigration by 70% (±25.8%). Inhibition of cor-
tactin expression in these ICAM-1–deficient endothelial cells 
did not inhibit neutrophil transmigration any further, whereas 
in ICAM-1 retransfectants, cortactin siRNA inhibited neu-
trophil transmigration by 31.2 ± 8.4%. Thus, in the absence of 
ICAM-1, cortactin does not contribute to neutrophil trans-
endothelial migration, suggesting that cortactin acts by sup-
porting ICAM-1 functions.
Neutrophil transmigration through endothelial cell layers 
is accompanied by the clustering of ICAM-1 around adher-
ing leukocytes, which strengthens cell adhesion and thereby   
Table I.  Hemodynamic parameters of cortactin-deficient and WT littermate mice
Genotype Venules Diameter Centerline velocity Wall shear rate
µm mm/s 1,000/s
CortactinWT/WT 26 36.8 ± 4.7 3.65 ± 0.1 1.02 ± 0.18
Cortactindel/del 22 30.3 ± 7.3a 3.67 ± 0.11 1.31 ± 0.31a
Data are presented as mean ± SD of all examined venules.
aP < 0.01.
Figure 6.  Loss of cortactin causes an ICAM-1–dependent reduction of leukocyte transmigration. (A) Human primary neutrophils were allowed 
to transmigrate through a TNF-activated monolayer of HUVECs on transwell filters (5-µm pore size) transfected with either control (ctrl) or cortactin-
specific siRNAs. (B) Transmigration of mouse PMNs through a TNF-activated monolayer of MLECs from CttnWT/WT (WT) and Cttndel/del (KO) mice on trans-
well filters (3-µm pore size). The amount of transmigrated neutrophils is displayed as the percentage of total applied cells. (C) Micrographs of HUVECs 
transfected with control and cortactin siRNA or of MLECs from CttnWT/WT (WT) and Cttndel/del (KO) mice, grown on transwell filters parallel to the experi-
ments shown in A and B and stained for VE-cadherin. Bar, 20 µm. (A–C) Experiments were independently performed three times. (D) ICAM-1–deficient 
(KO) and ICAM-1–retransfected (retr.) endothelioma cells were transfected with either control or cortactin-specific siRNAs. 48 h later, cell lysates were 
immunoblotted for cortactin expression (top). Equal loading was controlled by blotting for tubulin (bottom). (E) Bone marrow–derived murine PMNs  
were allowed to transmigrate across TNF-activated ICAM-1–deficient (KO) and ICAM-1–retransfected endothelioma cell lines transfected with either  
control or cortactin-specific siRNA. (D and E) Experiments were performed three times. (F) Transmigration of human PMNs through HUVEC monolayers 
transfected with either control or cortactin-specific siRNA and additionally treated with either 100 µM 8-pCPT-2Me-cAMP (+007) or vehicle (007).  
(A, B, E, and F) All data are means ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.005 (n = 6 in three independent experiments; n.s., not significant).1728 Cortactin regulates endothelial barrier functions | Schnoor et al.
Constitutively active (CA) RhoG restores Cttndel/del defects  
in transmigration
To  determine  whether  the  defect  in  ICAM-1–triggered 
RhoG activation in Cttndel/del MLECs would be responsible 
for impaired neutrophil transmigration, we tested whether 
transfection of CA-RhoG would rescue the phenotype. We 
found that CA-RhoG but not WT RhoG indeed partially 
restored the formation of ICAM-1–containing rings around 
neutrophils adhering to Cttndel/del MLECs (Fig. 8 B). In addi-
tion, transmigration efficiency of neutrophils across a mono-
layer  of  these  cells  was  largely  restored  with  CA-RhoG   
(Fig. 8 C). We conclude that the defect in ICAM-1–triggered 
activation of RhoG is responsible for impaired ICAM-1   
clustering and neutrophil transmigration in cortactin-deficient 
endothelial cells.
DISCUSSION
Analyzing  cortactin-deficient  mice,  we  show  for  the  first 
time that this actin-remodeling protein is required in endo-
thelial cells, not in neutrophils, for optimal efficiency of   
neutrophil recruitment to inflamed tissue. Loss of cortactin 
caused an increase in rolling velocity and a decrease of neu-
trophil adhesion to the vessel wall. Thus, endothelial cortactin 
is required for slowing down rolling neutrophils and for firm 
adhesion to the vessel wall. Interestingly, cortactin was not 
required for the support of selectin-mediated rolling but for 
the slowing down of rolling mediated by 2-integrins and 
their ligands. In addition, formation of ICAM-1–containing 
clusters was disturbed, providing a possible explanation for the 
decreased numbers of neutrophils adhering to the vessel wall. 
Searching for a mechanism for this defect, we found that cor-
tactin deficiency blocked the activation of RhoG triggered 
by ICAM-1 engagement, and CA-RhoG partially restored 
ICAM-1  clustering  and  neutrophil  transmigration  across   
cortactin-deficient endothelial cells. Independent of the role 
in contact with cortactin-depleted HUVECs. Here, only 
25% showed ICAM-1–positive ring structures, and 75%   
of these cells showed no ICAM-1 rings. These results de-
monstrate that the presence of cortactin is required for 
proper  formation  of  ICAM-1–enriched  clusters  around   
adhering PMNs, thus allowing for correctly regulated neutro-
phil recruitment.
To test whether the lack of cortactin would impair neu-
trophil  transmigration  via  the  reduced  level  of  activated 
Rap1, we tested whether the specific activator 8-pCPT-
2Me-cAMP (007) of Epac/Rap1 would affect transmigration 
of human PMNs through HUVEC monolayers either treated 
with control siRNA or with cortactin siRNA. As shown in 
Fig. 6 F, 007 had no effect on neutrophil transmigration, sug-
gesting that Rap1 is not involved in mechanisms whereby 
cortactin supports neutrophil extravasation.
Cortactin is required for ICAM-1–triggered activation  
of RhoG
RhoG has recently been reported to be required for the for-
mation of leukocyte-surrounding ICAM-1 clusters and leuko-
cyte  transmigration  (van  Buul  et  al.,  2007).  The  activation   
of RhoG was found to be triggered by leukocyte engage-
ment of ICAM-1. This prompted us to test whether RhoG 
activation  would  be  compromised  in  Cttndel/del  MLECs. 
Therefore, we incubated primary isolated MLECs of CttnWT/WT 
and Cttndel/del mice with beads either loaded with antibodies 
against mouse ICAM-1 or with control antibodies and per-
formed  RhoG  activation  assays  using  the  effector  protein 
ELMO (engulfment and cell motility gene) in pull-down ex-
periments. As shown in Fig. 8, engagement of ICAM-1 trig-
gered activation of RhoG in CttnWT/WT but not in Cttndel/del 
MLECs. Thus, cortactin is required for ICAM-1–triggered 
activation of RhoG, a signaling process involved in the trans-
migration of neutrophils.
Figure 7.  Reduced leukocyte transmigration after down-regulation of cortactin is accompanied by impaired formation of ICAM-1 clusters. 
HUVECs were incubated for 20 min with human primary PMNs as described in Materials and methods followed by fixation and immunofluorescence 
microscopy. (A) HUVECs transfected with control (ctrl) siRNA show ICAM-1 (red) and cortactin (green) containing ring structures surrounding a PMN. 
HUVECs transfected with cortactin-specific siRNA show no ICAM-1 clustering around the PMN. Associated leukocytes were visualized by transmitted light 
(left). Bar, 5 µm. (B) Apically adherent PMNs from randomly selected fields of three independent experiments were scored for the presence of ICAM-
  1–containing ring structures. A representative experiment with the percentage of analyzed cells is displayed. A total of 112 PMNs (on cortactin-depleted 
HUVECs) and 119 PMNs (on cortactin-positive HUVECs) were analyzed.JEM Vol. 208, No. 8 
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rolling velocity by activating the neutrophil integrins LFA-1 
and Mac-1, which participate in this process via binding to 
ICAM-1 and additional endothelial ligands (Kunkel et al., 
2000; Dunne et al., 2002; Wang et al., 2007; Zarbock et al., 
2007, 2008; Miner et al., 2008). Slowing down neutrophil 
rolling has so far only been studied as a neutrophil process 
requiring signaling that triggers integrin activation (Zarbock 
and Ley, 2009). We show here that also endothelial adhesion 
molecules require cytosolic components that are necessary to 
enable them to support neutrophil rolling. With cortactin, 
we have identified the first intracellular component in endo-
thelial cells that is required in vivo for the slowing down of 
rolling neutrophils.
In vitro studies have suggested that E-selectin requires 
cytoskeletal  components  for  its  function.  Various  actin-
  associated proteins were copurified with E-selectin upon inter-
action with neutrophils (Yoshida et al., 1996), one of them 
being cortactin (Tilghman and Hoover, 2002). Although one 
study suggested that the cytoplasmic tail of E-selectin would 
be dispensable for the adhesive function of E-selectin (Kansas 
and  Pavalko,  1996),  another  showed  that  clustering  of   
E-selectin in either clathrin-coated pits or lipid rafts enhanced 
neutrophil adhesion under flow (Setiadi and McEver, 2008). 
Collectively, these results suggest that the cytoskeleton can 
influence E-selectin function. In this context, it is remarkable 
that cortactin deficiency, although clearly affecting rolling 
velocity in vivo, did not affect rolling when the function of 
2-integrins was blocked. Thus, cortactin only contributes to 
the rolling velocity if the integrins on PMNs are functional. 
This is indirect evidence suggesting that cortactin is required 
for the transition of fast to slow neutrophil rolling and this 
process depends on the adhesive function of 2-integrin   
ligands. Of the three 2-integrin ligands ICAM-1, ICAM-2, 
and JAM-A, only ICAM-1 has a clearly detectable although 
only small role in slow rolling (Ley et al., 1998; Steeber et al., 
1998), whereas ICAM-2 seems not to serve as a rolling ligand 
of LFA-1 (Dunne et al., 2003) and JAM-A does not appear 
to play a role in adhesion under flow (Ostermann et al., 
2002). It will be interesting to study in the future how cor-
tactin participates in the incorporation of ICAM-1 and possi-
bly  other  2-integrin  ligands  into  the  rolling  process. 
Possibilities range from the support of ligand miniclusters or 
even selectin/integrin ligand heteroclusters to the organiza-
tion of a cortical actin network that may provide a plat-
form to stabilize forces that pull on ICAM-1 and/or other   
2-integrin ligands.
In addition to the contribution to neutrophil rolling, our 
results reveal that cortactin is also needed in vivo for firm ad-
hesion of neutrophils in inflamed venules and for clustering 
of ICAM-1, which supports firm adhesion of leukocytes to 
endothelial cells and subsequent transmigration (Barreiro   
et  al.,  2002;  Carman  et  al.,  2003;  Carman  and  Springer, 
2004). Other cytoskeletal adaptors that are important for the 
formation of such structures are the ERM (ezrin, radixin, and 
moesin) proteins (Barreiro et al., 2002) and filamin B, which 
was found to be involved in ICAM-1 recruitment to adhering 
of cortactin in neutrophil extravasation, we found that cor-
tactin is essential to maintain endothelial cell contact integ-
rity. Gene deficiency led to enhanced basal permeability for 
high molecular weight substances. This effect could be res-
cued by directly activating Epac/Rap1 with a stable cAMP 
derivative, suggesting that cortactin acts upstream of Rap1. 
Thus, cortactin affects leukocyte extravasation and endothe-
lial cell contact integrity by controlling the activity of two 
different GTPases in two independent mechanisms.
Neutrophil capturing, rolling, and adhesion represent 
consecutive steps of a complex process that requires the interplay 
of selectins and neutrophil integrins. It is well documented that 
P- and E-selectin mediate capturing and rolling of neutro-
phils (Vestweber and Blanks, 1999). Besides directly mediat-
ing rolling via binding to various neutrophil selectin ligands 
(McEver, 2002; Hidalgo et al., 2007), the endothelial selec-
tins intensify the rolling interactions and thereby slow down 
Figure 8.  Cortactin is required for ICAM-1–triggered activation of 
RhoG. (A) Primary MLECs isolated from CttnWT/WT (WT) and Cttndel/del (KO) 
mice were incubated for 30 min with beads loaded with either control 
antibody (IgG) or the mAb YNI against ICAM-1. Active RhoG was pulled 
down from cell lysates with ELMO-GST and detected in immunoblots 
(top). Total RhoG levels subjected to pull-downs were controlled by blot-
ting aliquots of the cell lysates (bottom). Quantification of signal intensity 
of the pulled down material is depicted below. (B) MLECs from CttnWT/WT 
(WT) and Cttndel/del (KO) mice transfected with WT RhoG or CA-RhoG were 
incubated for 20 min with mouse PMNs followed by fixation and immuno-
fluorescence microscopy for ICAM-1. 109 PMNs (on WT cells with WT 
RhoG), 102 PMNs (on WT cells with CA-RhoG), 81 PMNs (on KO cells with 
WT RhoG), and 92 PMNs (on KO cells with CA-RhoG) were analyzed for 
the presence of surrounding ICAM-1 rings. (C) Transmigration of mouse 
PMNs through a TNF-activated monolayer of MLECs from CttnWT/WT (WT) 
and Cttndel/del (KO) mice transfected with WT RhoG or CA-RhoG. The 
amount of transmigrated neutrophils is displayed as the percentage of 
total applied cells. Data are presented as mean ± SD. ***, P < 0.005.  
(A–C) Experiments were independently performed three times.1730 Cortactin regulates endothelial barrier functions | Schnoor et al.
Jacobson et al., 2006). However, silencing of cortactin ex-
pression in these studies blocked S1P or ATP-stimulated   
enhancement of the barrier function but had no effect on the 
baseline permeability of cultured pulmonary endothelial cells. 
Thus,  a  requirement  of  cortactin  for  the  maintenance  of 
baseline barrier integrity as shown in our cortactin-deficient 
mouse model has not yet been described. Our findings that 
cortactin expression supports Rap1 activation and that stimu-
lation of Epac/Rap1 with 8-pCPT-2Me-cAMP can rescue 
endothelial  cell  contact  integrity  in  cells  lacking  cortactin 
suggests that Rap1 acts downstream of cortactin in the con-
trol of endothelial cell contact integrity. In contrast, it has 
been reported that activation of Epac/Rap1 by 8-pCPT-
2Me-cAMP results in enhanced barrier integrity through im-
proved VE-cadherin–dependent cell adhesion and increased 
cortical actin formation, which was accompanied by translo-
cation of cortactin to cell junctions (Fukuhara et al., 2005; 
Kooistra et al., 2005). In addition, Epac/Rap1 activation was 
suggested to lead to Rac1 activation and translocation to cell 
junctions, which was accompanied by cortactin recruitment 
to endothelial junctions (Baumer et al., 2008). Thus, a posi-
tive feedback loop may exist where cortactin supports Rap1 
activation and at the same time activated Rap1 stimulates the 
recruitment of more cortactin to cell contacts.
In numerous in vitro studies, cortactin has been impli-
cated to be involved in many important cellular processes 
that  require  actin  remodeling  (e.g.,  Selbach  and  Backert, 
2005; Ammer and Weed, 2008; Ren et al., 2009). Through 
physical  interactions  with  actin  filaments  and  the  Arp2/3 
complex, cortactin is thought to promote Arp2/3-dependent 
actin filament nucleation. However, whether the vascular 
phenotype of cortactin-deficient mice we describe here is   
indeed caused by a lack of a direct impact of cortactin on the 
actin cytoskeleton remains to be determined.
Recent studies investigating ES cell–derived fibroblasts 
harboring a null mutation analogous to the one used here or 
primary cells derived from independently generated cortactin-
deficient mice consistently demonstrated a nonessential role 
for cortactin in actin remodeling (Lai et al., 2009; Tanaka   
et al., 2009). Although we found a slight induction of actin 
fibers that cross through the body of cortactin-deficient cells 
(Fig. S3), the nature of these fibers and potential functions are 
unclear. Instead of major effects on actin remodeling, cortactin 
was found to be involved in platelet-derived growth factor–
induced  signaling  to  Rho-GTPases  (namely  Rac-1  and 
Cdc42) and in cell migration (Lai et al., 2009). The data   
suggest  that  cortactin  may  operate  in  signaling  to  actin 
polymerization more indirectly than previously anticipated, 
possibly through contributing to the temporal and spatial 
regulation of activation of selected Rho GTPases. This is   
in good agreement with our results on the role of cortactin 
for the regulation of Rap1 and RhoG activity in endothe-
lial cells.
Other  cortactin-deficient  mouse  models  have  recently 
been presented with various phenotypes. Tanaka et al. (2009) 
generated mice homozygous for a cortactin allele devoid of 
leukocytes (Kanters et al., 2008). As a mechanism whereby 
cortactin deficiency impairs the formation of ICAM clusters 
and neutrophil transmigration, we found that cortactin is es-
sential for the activation of RhoG, triggered by the engage-
ment  of  ICAM-1  on  the  surface  of  endothelial  cells. 
ICAM-1–triggered RhoG activation was recently demon-
strated to be critical for the formation of ICAM-1 clusters 
and also for neutrophil transmigration (van Buul et al., 2007). 
Interestingly,  neither  the  depletion  of  RhoG  via  siRNA   
(van Buul et al., 2007) nor cortactin deficiency (this study)   
impaired  neutrophil  adhesion  to  endothelial  cells  in  static   
adhesion assays. In the light of our in vivo results, this suggests 
that  ICAM-1–containing  clusters  affect  neutrophil  arrest 
only under in vivo flow conditions.
Our results are in agreement with studies by Yang et al. 
(2006a,b) who showed that cortactin supports the clustering 
of ICAM-1 into ring-like structures around neutrophils at-
tached to HUVECs. However, although they found that   
silencing  of  cortactin  inhibited  neutrophil  transmigration 
through endothelial cell layers under flow conditions, they 
found no effect on neutrophil adhesion to the apical surface 
of  endothelial  cells.  Rolling  velocity  was  not  reported  in 
these studies, and the fact that no inhibitory effects on neu-
trophil attachment were detectable might be caused by dif-
ferences between in vitro and in vivo conditions, or not least 
to the fact that siRNA cannot block expression as completely 
as gene deficiency. Interestingly, however, the study by Yang 
et al. (2006b) and also our in vitro results may hint toward an 
additional function of cortactin downstream of neutrophil 
rolling and adhesion, which could be a role in the diapedesis 
process itself or in the initiation of this process. In the light of 
these results, it is important to note that ICAM-1 cross-linking 
triggers tyrosine phosphorylation of cortactin. This suggests 
that cortactin is involved in ICAM-1 signaling (Durieu-
Trautmann et al., 1994), which is in good agreement with 
our finding that cortactin is required for ICAM-1–triggered 
activation  of  RhoG.  ICAM-1  clustering  triggers  various   
signals that may be involved in the destabilization of endo-
thelial junctions (Adamson et al., 1999; Etienne-Manneville 
et al., 2000; Allingham et al., 2007; Turowski et al., 2008). 
Whether cortactin participates in neutrophil diapedesis in vivo 
can currently not be decided because of its prominent role   
in neutrophil rolling and firm adhesion.
Our in vivo analysis of vascular permeability and also our 
in vitro results showed that cortactin is required to maintain 
the barrier function of the vasculature. Whereas our in vitro 
results clearly show that it is endothelial cortactin that is re-
quired for endothelial cell contact integrity, it is also possible 
that in vivo cortactin in perivascular cells may additionally 
contribute to the integrity of the vessel wall. Previous in vitro 
studies suggested that cortactin is required for signaling mech-
anisms that enhance the stability of endothelial cell contacts. 
Treatment of pulmonary endothelial cells with either S1P or 
ATP led to barrier enhancement via junctional translocation   
of  cortactin  accompanied  by  translocation  and  activation  of 
Rac1 and MLCK (myosin light chain kinase; Dudek et al., 2004; JEM Vol. 208, No. 8 
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Generation of cortactin-deficient mice. Two independent targeting 
vectors harboring neomycin and puromycin cassettes, respectively, were 
previously used to allow consecutive targeting of both cortactin alleles in 
ES cells that were then injected into blastocysts giving rise to chimeric 
embryos that were used to isolate puromycin- and neomycin-resistant   
fibroblast cultures (Lai et al., 2009). To generate cortactin-deficient mice, 
ES cells (line IGD3.2) were modified by homologous recombination of 
only one allele with the neomycin-containing construct shown in Fig. 1 A. 
In brief, the targeting vector comprised exons 6–9 of the Cttn gene, in 
which a neomycin cassette (flanked by Flp recombinase recognition sites) 
was inserted after exon 7 and two loxP sites were inserted flanking this 
exon. Targeted Cttn mut/WT ES (F1) cells were injected into C57BL/6J 
host blastocysts, which were then transferred into pseudopregnant fe-
males. Germline transmission of the targeted ES cells was confirmed by 
genotyping following standard procedures (DeChiara, 2001). The neomycin   
cassette was removed by crossing with mice expressing Flp recom-
binase  (Rodríguez  et  al.,  2000).  Systemic  Cre  recombinase–mediated   
excision of exon 7 was achieved by crossing males carrying the floxed 
Cttn allele with transgenic females expressing Cre under the control of   
the  human  K14  promoter,  allowing  deletion  in  the  oocyte  (Hafner   
et al., 2004).
Genotyping. Genomic DNA was prepared from mouse tail samples as de-
scribed previously (DeChiara, 2001). Genotyping for the WT, Cttn-targeted, 
and neomycin-containing deleted (delneo) alleles was described previously 
(Lai et al., 2009). Genotyping for the floxed (neo deleted) versus WT alleles 
was performed in a standard PCR setup using the following set of PCR 
primers: forward, fS, 5-CTCTGCTCTGTGCTTTGACC-3; and reverse,   
fA,  5-GTGCTGTTCATCCACAATGC-3,  producing  PCR  fragments 
with a size of 150 bp (WT allele) and 370 bp (floxed allele). For the   
genotyping in Fig. 1 B, PCR primer sets forward, dS, (5-AGGGTCTGAC-
CATCATGTCC-3) and reverse, fA (see above), were used, and PCR 
products generated were 400 bp for the deleted (KO) and 900 bp for the 
WT allele.
Intravital  microscopy.  3  h  before  cremaster  muscle  exteriorization,   
Cttndel/del and sex- and age-matched CttnWT/WT mice received 500 ng TNF   
(PeproTech) in 0.3 ml saline intrascrotally. Mice were anesthetized with an 
intraperitoneal injection of 125 mg/kg ketamine hydrochloride (Sanofi) and 
12.5 mg/kg xylazine (TranquiVed; Phoenix Scientific), and the cremaster 
muscle  was  prepared  for  intravital  microscopy  as  described  previously   
(Zarbock et al., 2007, 2008). Postcapillary venules with a diameter between 
20 and 40 µm were recorded using an intravital upright microscope (Axioskop; 
Carl Zeiss) with a 40× 0.75 saline immersion objective. Leukocyte rolling 
velocity, leukocyte rolling flux fraction, and leukocyte firm adhesion were 
determined by transillumination intravital microscopy. Leukocyte extravasa-
tion was investigated by reflected light oblique transillumination microscopy 
(Mempel et al., 2003; Mueller et al., 2010). Recorded images were analyzed 
using ImageJ (National Institutes of Health) and AxioVision (Carl Zeiss) 
software. The leukocyte rolling flux fraction was calculated as the percentage 
of total leukocyte flux. Emigrated cells were determined in an area reaching 
out 75 µm to each side of a vessel over a distance of 100 µm vessel length 
(representing 1.5 × 104 µm2 tissue area). The microcirculation was recorded 
using a digital camera (Sensicam QE; PCO Inc.). Blood flow centerline   
velocity was measured using a dual photodiode sensor system (Circusoft   
Instrumentation). All animal experiments were approved by the Animal   
Care and Use Committees of the University of Münster and the local gov-
ernment. Animals were kept in a barrier facility under special pathogen-
  free conditions.
Bone marrow chimeras. Mixed chimeric mice were generated by per-
forming bone marrow transplantation. In brief, bone marrow cells isolated 
from cortactin-deficient and WT littermate mice were separately injected i.v. 
into lethally irradiated WT mice (9.5 Gy). Experiments were performed   
8 wk after bone marrow transplantation.
exon 5 and succeeded in isolating embryonic fibroblasts on 
embryonic day (E) 15 of development. Although it was not 
mentioned whether these mice are viable beyond E15, con-
sidering  the  results  described  here,  such  a  scenario  seems 
likely. In contrast, Yu et al. (2010) generated a cortactin-
  deficient mouse model using a gene-trap vector. Although 
they reported heterozygous animals being viable and fertile, 
they failed to obtain homozygous offspring. As an explana-
tion for this defect, the authors concluded that cortactin plays 
a role in asymmetric division of oocytes. Although a lack of 
embryonic lethality in the mouse model described by Tanaka 
et al. (2009) remains to be experimentally demonstrated, it is 
tempting to speculate that the strong phenotype observed by 
Yu et al. (2010) may be explained, at least in part, by dominant-
negative effects caused by expression of N-terminal cortactin 
residues fused to -galactosidase in this gene-trap mutant.   
A potential role of cortactin in spermiogenesis was previously 
proposed by Kai et al. (2004) based on the analysis of mice 
(C57BL/6 × C3H mixed genotype) carrying a large genomic 
deletion including the cortactin locus. At least for mice of the 
genotype analyzed here (129SV × C57BL/6 mixed back-
ground and C57BL/6 sixth backcross), we can exclude this 
function for cortactin because our cortactin-deficient male 
mice are fertile.
In conclusion, our results establish cortactin as an essential 
physiological component of the molecular machinery that 
controls  basal  vascular  permeability  by  supporting  barrier   
integrity of the endothelium in vivo. In addition, cortactin   
is required for proper functioning of two types of ICAM-1–
mediated  endothelial–neutrophil  interactions  in  vivo:  the 
slow rolling of neutrophils, which depends on the contribu-
tion of ICAM-1, and the firm adhesion that is mediated by 
clustered ICAM-1. Thus, cortactin is crucial for stabilizing 
the endothelial barrier at endothelial cell contacts and sup-
porting neutrophil accumulation at the luminal surface of the 
endothelium leading to neutrophil extravasation.
MATERIALS AND METHODS
Antibodies and reagents. The following commercial primary antibodies 
were used: monoclonal anticortactin (clone 4F-11; Millipore), polyclonal 
anticortactin (clone GK18; Sigma-Aldrich), anti–VE-cadherin (clone C19; 
Santa Cruz Biotechnology, Inc.), anti–ICAM-1 (clone R6-5-D6 [BioX-
Cell];  clone  YN1/1.7  [Takei,  1985]),  anti–-tubulin  (clone  B-5-1-2; 
Sigma-Aldrich), monoclonal anti-CD11a and anti-CD11b (clones M17/4 
and M1/70; BD), and anti–PECAM-1 (clone MEC13.3; BioLegend). Anti-
bodies against mouse P-selectin (clone RB40/34; Bosse and Vestweber, 
1994), mouse E-selectin (clone UZ4; Hammel et al., 2001), mouse VE-
  cadherin (polyclonal serum C5 and clone 11D4), and ESAM (VE19) have 
been described previously (Gotsch et al., 1997; Nasdala et al., 2002). pAbs 
against JAM-A (Khandoga et al., 2009) and mAb against mouse VCAM-1 
(Hahne et al., 1993) are as previously described. Fluorescently labeled sec-
ondary antibodies were purchased from Invitrogen. Peroxidase-labeled sec-
ondary antibodies were purchased from Dianova. F-actin was stained using 
Alexa  Fluor  568–conjugated  phalloidin  (Invitrogen).  Epac  was  activated   
using 8-pCPT-2Me-cAMP (Biolog). The mAb against RhoG and the ex-
pression construct for ELMO-GST were gifts of M.A. Schwartz (University 
of Virginia, Charlottesville, VA). ELMO-GST was purified from BL-21 bacteria 
using glutathione–Sepharose 4B (GE Healthcare) as described previously 
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mounted in fluorescent mounting medium (Dako) and examined in a con-
focal laser-scanning microscope (Axiovert 200 M LSM510; Carl Zeiss).
For the determination of ICAM-1 clusters, adhesion of leukocytes to 
TNF-activated  HUVECs  was  analyzed  as  described  previously  (Carman   
et al., 2003), except for that platelet-activating factor and MnCl2 treatments 
were omitted. In brief, 500,000 PMNs were directly added to confluent 
HUVEC layers on a round 12-mm coverslip. After 20 min, cells were fixed 
in 4% paraformaldehyde and stained for microscopy.
Permeability assay. HUVECs or bend.3 endothelioma were nucleofected, 
seeded on 6.5-mm-diameter transwell filters (Corning) with 0.4-µm pore size, 
coated with 0.01% fibronectin, and cultured for 48 h before starting the assay.   
4 × 104 MLECs were seeded per 6.5-mm-diameter transwell filters with 3-µm 
pore size, coated with 0.01% fibronectin, and cultured for 1 wk before starting 
the assay. 0.25 mg/ml FITC-dextran (250 or 150 kD; Sigma Aldrich) was added 
to the top chamber, and diffusion was allowed for 30 min in the presence or ab-
sence of 100 µM 8-pCPT-2Me-cAMP at 37°C. Fluorescence in the lower 
chamber was measured using a spectrofluorimeter (Synergy-2; BioTek). Con-
fluence of cells was determined by immunofluorescence staining for VE-cadherin 
for each assay. Transendothelial electrical resistance of HUVEC monolayers 
transfected and cultivated as described in Cell culture and Transfections was 
measured using a CellZScope device (nanoAnalytics) according to the manufac-
turer’s instructions. The resistance of empty filters of 8.7 ± 0.6 Ω*cm2 was sub-
tracted from the values measured for the HUVEC monolayers.
Transmigration assay. PMN transmigration experiments with HUVEC 
and bend.5 monolayers, which were activated for 16 h with 5 nM TNF, 
were performed on 6.5-mm-diameter transwell filters with 5-µm pore size 
48 h after transfection with siRNAs. 4 × 104 MLECs were seeded per 6.5-mm-
diameter transwell filters with 3-µm pore size, coated with 0.01% fibronec-
tin, and cultured for 1 wk before starting the assay. In brief, cells were 
washed with 199 medium containing 20% FCS and 25 mM Hepes. The   
upper reservoir was then filled with 100 µl of supplemented 199 medium 
containing 0.5 × 106 PMNs. After 1 h, the numbers of transmigrated PMNs 
in the lower reservoirs containing 500 µl of supplemented 199 medium were 
quantified using a Casy Cell Counter (Innovatis). PMN migration into the 
lower reservoirs is expressed as the percentage of total applied PMNs. Endo-
thelial monolayers were controlled by immunofluorescence staining for   
VE-cadherin for each assay.
GTPase activity assays. To test for the activation levels of the small GT-
Pase Rap1 in the absence of cortactin, GST-RalGDS-RBD pull-down ex-
periments of Rap1-GTP were performed using the Rap1 Activation kit 
(Millipore) according to the manufacturer’s instructions. Levels of active 
Rap1 were detected by Western blot using the antibody provided with the 
kit (Millipore). Western blots were scanned and quantified using ImageJ. To 
activate  RhoG  by  ICAM-1  cross-linking,  a  100-µl  slurry  of  Dynabeads   
(Invitrogen) was loaded with 30 µg anti–ICAM-1 mAb YN1/1.7 (over-
night) and added to a confluent monolayer of TNF-activated MLECs (7 × 106 
cells per 100-mm dish) for 30 min at 37°C. Unbound beads were washed off 
with ice-cold PBS before cell lysis. Aliquots of the cell lysates were snap fro-
zen to determine later the total RhoG content. Active RhoG was precipi-
tated from the remaining cell lysate using 50 µg ELMO-GST per sample 
(100-mm dish) as previously described (Meller et al., 2008). Levels of total 
and active RhoG were determined by Western blot using an anti-RhoG 
mAb provided by M.A. Schwartz.
Statistical analysis. Data are presented as mean with SD of the mean.   
Statistical significance was assessed using the Student’s t test. 2 tests were 
performed for the mating statistics to test the probability that deviation be-
tween the observed and the expected values is caused by chance.
Online supplemental material. Fig. S1 shows that the expression of various 
endothelial surface receptors is not altered in the absence of cortactin. Fig. S2   
shows that cortactin is undetectable in murine leukocytes and that systemic 
Determination of vascular permeability. Modified Miles assays were 
performed as described previously (Oura et al., 2003; Mamluk et al., 2005; 
Wegmann et al., 2006). In brief, three 8–12-wk-old Cttndel/del and three sex- 
and age-matched CttnWT/WT mice were used per assay. Evans blue dye was 
injected into the tail vein, and 10 min later, 50 µl PBS or 100 ng histamine 
in 50 µl PBS was intradermally injected into the back skin that was shaved 
24 h before the assay. 30 min later, animals were sacrificed, and skin areas 
surrounding the sites of injections were excised. Evans blue dye was ex-
tracted from the skin by incubation in formamide for 5 d at room tempera-
ture. Subsequently, the extracted dye was measured at 620 nm using a 
spectrophotometer. To exclude the possibility that the increase of Evans 
blue simply reflected the increase in blood flow, we measured the quantity 
of hemoglobin in the tissue by noninvasive white light spectroscopy using   
an O2C spectroscopy device (LEA Medizintechnik). The quantity of hemo-
globin in the histamine-injected skin only increased by 20%. Thus, the   
increase of Evans blue detected in the histamine-stimulated skin was mainly 
caused by leakage and not by increased quantity of blood in the micro-
vessel system.
Cell culture. HUVECs were isolated as described previously (Baumeister   
et  al.,  2005)  and  propagated  in  EGM  endothelial  cell  growth  medium 
(Lonza).  ICAM-1/  endothelioma  bendI1.1  and  ICAM-1–retransfected 
bendI1.1 cells (provided by B. Engelhardt, University of Bern, Bern, Swit-
zerland) were propagated as described previously (Lyck et al., 2003). The 
mouse endothelioma cell lines bend.3 and bend.5 cells were cultivated as 
described previously (Nottebaum et al., 2008). Human PMNs were isolated 
from the blood of healthy volunteers by Ficoll density gradient centrifuga-
tion as described previously (Moll et al., 1998). Murine bone marrow–
  derived leukocytes were isolated as described previously (Bixel et al., 2007). 
Primary  MLECs  were  isolated  from  8-wk-old  Cttndel/del  and  littermate 
CttnWT/WT mice as described previously (Schniedermann et al., 2010).
Transfections. siRNAs directed against the messenger RNAs of cortactin 
(QIAGEN) were transfected into HUVECs or mouse endothelioma cell 
lines by nucleofection (Lonza) as described previously (Nottebaum et al., 
2008). Target sequences of oligonucleotides were as follows: human cortactin-
  5  (5-CACCAGGAGCATATCAACATA-3),  human  cortactin-6   
(5-ATGCAACTTATTGTATCTGAA-3), murine cortactin-5 (5-CAGA-
GATGTGCTAGTGGCTTA-3), and murine cortactin-7 (5-CACCAA-
CATAGAAATGATTGA-3). The AllStars Negative Control siRNA (no 
sequence provided; QIAGEN) served as nonsilencing negative control. Effi-
ciency of knockdown was evaluated by Western blot or immunofluores-
cence staining of cortactin. Experiments were started 48 h after transfection. 
The two mouse and two human oligonucleotides each inhibited cortactin 
expression, permeability, and transmigration with similar efficiency. Experi-
ments are shown with human cortactin-5 and mouse cortactin-5. The 
cDNA construct for CA and WT RhoG (Meller et al., 2008) was transfected 
into MLECs by nucleofection using the same conditions as for siRNA.
Western blotting. Equal protein amounts of cell lysates were separated by 
SDS-PAGE and transferred electrophoretically to polyvinylidenefluoride mem-
branes (Millipore). After incubation in PBS containing 5% skim milk for 1 h to 
block unspecific binding, the membranes were probed in primary antibodies   
either for 4°C over night or for 1 h at 37°C, washed three times in PBS contain-
ing 0.5% skim milk and 0.05% Tween 20 for 10 min each, and incubated with 
species-specific peroxidase-conjugated secondary antibody (Dianova) for 1 h   
at 37°C. Chemiluminescence signals were recorded on Hyperfilm x-ray films 
(GE Healthcare). Tubulin blots were performed as loading controls.
Immunofluorescence microscopy. Cells were cultured as described in 
Cell culture, rinsed with PBS, and fixed in 100% ethanol at 20°C for   
20 min. After washing, cells were incubated for 1 h in PBS containing 3% BSA 
to block unspecific binding. Coimmunolabeling with primary antibodies 
was performed for 1 h followed by washing and incubation with species-specific 
fluorescently labeled secondary antibodies (Invitrogen). Preparations were JEM Vol. 208, No. 8 
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